These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22832386)
21. Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation. Massa R; Pozzessere S; Rastelli E; Serra L; Terracciano C; Gibellini M; Bozzali M; Arca M Muscle Nerve; 2016 Apr; 53(4):644-8. PubMed ID: 26600210 [TBL] [Abstract][Full Text] [Related]
22. Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis. Garcia MA; Rojas JA; Millán SP; Flórez AA J Clin Neurosci; 2018 Dec; 58():207-209. PubMed ID: 30352762 [TBL] [Abstract][Full Text] [Related]
23. Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Campagna F; Nanni L; Quagliarini F; Pennisi E; Michailidis C; Pierelli F; Bruno C; Casali C; DiMauro S; Arca M Biochem Biophys Res Commun; 2008 Dec; 377(3):843-6. PubMed ID: 18952067 [TBL] [Abstract][Full Text] [Related]
24. Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients. Shahriyari H; Ramezani M; Nilipour Y; Okhovat AA; Kariminejad A; Aghaghazvini L; Fatehi F; Nafissi S Neuromuscul Disord; 2024 Feb; 35():19-24. PubMed ID: 38194732 [TBL] [Abstract][Full Text] [Related]
25. Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy. Hong D; Zheng J; Xin L; Xiang Y; Luan X; Cao L; Cong L; Fang P; Zhang J Clin Neuropathol; 2019; 38(4):157-167. PubMed ID: 30738494 [TBL] [Abstract][Full Text] [Related]
26. Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy. van de Weijer T; Havekes B; Bilet L; Hoeks J; Sparks L; Bosma M; Paglialunga S; Jorgensen J; Janssen MC; Schaart G; Sauerwein H; Smeets JL; Wildberger J; Zechner R; Schrauwen-Hinderling VB; Hesselink MK; Schrauwen P Circ Res; 2013 Mar; 112(5):e51-4. PubMed ID: 23449549 [No Abstract] [Full Text] [Related]
27. [Unusual phenotype of myopathy associated with a new PNPLA2 mutation]. Jousserand G; Streichenberger N; Petiot P Med Sci (Paris); 2016 Nov; 32 Hors série n°2():10-11. PubMed ID: 27869069 [No Abstract] [Full Text] [Related]
28. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Schweiger M; Lass A; Zimmermann R; Eichmann TO; Zechner R Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E289-96. PubMed ID: 19401457 [TBL] [Abstract][Full Text] [Related]
29. HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy. Fu X; Yang X; Wang X; Jia B; Ma W; Xiong H; Fang F; Ren X; Lv J Neuromuscul Disord; 2023 Sep; 33(9):81-89. PubMed ID: 37620213 [TBL] [Abstract][Full Text] [Related]
30. MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy. Pegoraro V; Missaglia S; Marozzo R; Tavian D; Angelini C Muscle Nerve; 2020 Feb; 61(2):253-257. PubMed ID: 31729045 [TBL] [Abstract][Full Text] [Related]
31. Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease. Muggenthaler M; Petropoulou E; Omer S; Simpson MA; Sahak H; Rice A; Raju H; Conti FJ; Bridges LR; Anderson LJ; Sharma S; Behr ER; Jamshidi Y Int J Cardiol; 2016 May; 210():41-4. PubMed ID: 26922712 [No Abstract] [Full Text] [Related]
32. Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>A. Xu C; Zhao Y; Liu J; Zhang W; Wang Z; Yuan Y Muscle Nerve; 2015 Jun; 51(6):922-7. PubMed ID: 25363365 [TBL] [Abstract][Full Text] [Related]
33. A novel Tavian D; Maggi L; Mora M; Morandi L; Bragato C; Missaglia S Genes Dis; 2021 Jan; 8(1):73-78. PubMed ID: 33569515 [TBL] [Abstract][Full Text] [Related]
34. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Fischer J; Lefèvre C; Morava E; Mussini JM; Laforêt P; Negre-Salvayre A; Lathrop M; Salvayre R Nat Genet; 2007 Jan; 39(1):28-30. PubMed ID: 17187067 [TBL] [Abstract][Full Text] [Related]
35. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy. Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421 [TBL] [Abstract][Full Text] [Related]
36. Late onset of neutral lipid storage disease due to a rare PNPLA2 mutation in a patient with myopathy and cardiomyopathy. Tian Y; Wang S; Wang F; Yi L; Dong M; Huang X Chin Med J (Engl); 2022 Oct; 135(19):2389-2391. PubMed ID: 36535014 [No Abstract] [Full Text] [Related]